DNTH
Dianthus Therapeutics Inc.
88.00$
-0.2%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.5% | 98.9% | 99.6% | 99.1% | 81.2% | 75.1% | 77.7% | 80.8% | 71.7% | 77.1% | 89.8% | 74.0% | |
| 81.7% | 73.8% | 86.2% | 85.2% | 9.5% | 6.1% | 2.9% | 4.1% | 9.7% | 9.6% | 50.3% | 9.1% | |
| 98.7% | 96.8% | 98.6% | 97.8% | 79.4% | 73.6% | 75.5% | 78.9% | 69.7% | 76.1% | 89.1% | 73.1% | |
| 0.4% | 0.3% | 0.2% | 0.5% | 0.4% | 0.2% | 0.3% | 0.0% | 0.9% | 0.0% | 0.1% | 0.0% | |
| – | – | – | 0.6% | – | – | – | – | – | – | – | – | |
| 7.3% | 5.9% | 2.6% | 2.9% | 4.6% | 5.8% | 5.7% | 7.1% | 5.4% | 7.1% | 3.7% | 3.4% | |
| 6.8% | 5.4% | 2.3% | 2.7% | 4.4% | 4.9% | 4.9% | 6.2% | 4.1% | 5.8% | 3.1% | 2.8% | |
| 0.2% | 0.2% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.0% | 0.1% | 0.0% | 0.0% | |
| 0.7% | 1.5% | 0.7% | 1.0% | 2.1% | 1.2% | 2.4% | 1.7% | 1.2% | 1.8% | 0.4% | 0.5% | |
| 92.7% | 94.1% | 97.4% | 97.1% | 95.4% | 94.2% | 94.3% | 92.9% | 94.6% | 92.9% | 96.3% | 96.6% | |
| -41.0% | -49.8% | -27.0% | -32.7% | -41.2% | -46.6% | -58.5% | -72.2% | -47.2% | -63.4% | -30.3% | -35.3% | |
| 20.3% | 2.5% | 6.7% | 9.3% | 9.7% | 9.4% | 10.3% | 11.0% | 6.5% | 7.1% | 3.9% | 4.6% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.